[Form 4] Willdan Group, Inc. Insider Trading Activity
Micah Chen, Executive Vice President & General Counsel of Willdan Group, Inc. (WLDN), reported insider transactions on 09/18/2025. He exercised 10,000 stock options with a $32.79 exercise price and acquired 10,000 shares through that exercise. Simultaneously, he sold 10,000 shares at $106 per share. After these transactions Chen beneficially owns 40,423 shares directly. His reported holdings include restricted stock units totaling 8,354 shares that vest on scheduled dates in 2026–2028 and 934 restricted shares vesting in March 2026, which are subject to continued service. The option exercised was part of grants under the company’s 2008 Performance Incentive Plan and had an original grant date of July 17, 2018, with an expiration of July 17, 2027. The Form 4 was signed by an attorney-in-fact on 09/22/2025.
- Transparent disclosure of exercise, sale prices, and remaining beneficial ownership
- Retention of meaningful equity through 40,423 directly owned shares and vested/vesting RSUs
- Immediate sale of exercised shares reduced insider's incremental exposure to share price appreciation
Insights
TL;DR: Insider exercised options and sold shares the same day, reducing short-term exposure while retaining significant restricted equity.
The reporting shows a routine exercise of vested options (10,000 shares at $32.79) and an immediate sale of 10,000 shares at $106, indicating a cash-out of option value while maintaining a substantial direct stake of 40,423 shares. The retained position includes multiple tranches of restricted stock units vesting 2026–2028, which aligns the executive’s interests with future service. Transaction sizes are modest relative to large-cap benchmarks but are material at an individual insider level. No additional compensatory grants or accelerated vesting are disclosed in this filing.
TL;DR: Transactions are typical for exercised, vested awards; disclosure is complete and follows Section 16 reporting requirements.
The Form 4 discloses both the option exercise and sale with required detail: exercise price, sale price, remaining beneficial ownership, and vesting schedules for restricted units. The inclusion of vesting schedules for restricted stock units provides clarity on future potential dilution and retention incentives. There is no indication of a Rule 10b5-1 plan or other plan-based transaction in the filing, and the filing was duly signed by an attorney-in-fact, meeting procedural expectations.